Fact CheckerSign in

NCT06988943Recruiting

Early Intervention Strategies for Lung Cancer

Construction and Evaluation of a Hospital-Community Health Collaboration Model Empowered by Digital Technology for Lung Cancer Screening

Source: ClinicalTrials.gov · Last updated 30 May 2025 · Not updated for over 12 months - ask the site whether it is still open

Brief summary (registry, in English)

Low-dose CT (LDCT)can detect and treat lung cancer earlier and more quickly, while expanded screening coverage helps reduce the incidence and mortality of respiratory diseases such as lung cancer. This study aims to conduct a single-arm cluster randomized trial of digitally enabled LDCT in Guangzhou to assess its intervention effectiveness and cost-effectiveness.

Status (registry)
Recruiting
Study type
Interventional
Enrollment
16000 (estimated)
First submitted
16 May 2025
Start date
25 Jun 2024
Primary completion date
Jun 2025
Lead sponsor
The First Affiliated Hospital of Guangzhou Medical University
Diseases
Lung cancer
NCT number
NCT06988943

What you commit to

  • Study type: Interventional
  • Planned participants: 16000
  • From 25 Jun 2024 to the primary completion date, Jun 2025
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Criteria the registry did not label

  • 1.Community Health Service Centers (Cluster Level)
  • Inclusion Criteria The community health service center must be located within one of the 11 districts of Guangzhou.
    • The center must manage a population of over 10,000 elderly individuals. The center should be equipped with at least one CT machine and have qualified medical personnel, such as radiologists, radiologic technicians, and nursing staff.
  • Exclusion Criteria Community health centers currently participating in other public health projects or studies that may affect screening results.
    • Community health service centers where researchers cannot collect data or conduct follow-up.
    • 2\. Screening Subjects (Individual Level)
  • Inclusion Criteria Aged 40-75 years. Residing in the community participating in the study for a long time. No known history of lung cancer and has not undergone lung cancer screening in the past three months.
    • Able to understand and willing to sign the informed consent form, and able to participate in long-term follow-up.
  • Exclusion Criteria Individuals diagnosed with lung cancer. Individuals with severe other health issues that make them unsuitable for CT imaging.
    • Individuals unable to understand the study protocol or who cannot provide informed consent due to cognitive impairments.
    • Individuals participating in other clinical trials that may affect the results of this study.
    • Individuals unable to undergo follow-up.

Age in the registry: 40 years to 74 years · Sex: All · Accepts healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Department of Cardiothoracic Surgery, the First Affiliated Hospital of Guangzhou Medical College
Coordinator of this site? Confirm its status
GuangzhouChinaRecruiting

This page is information, not medical advice. Discuss any trial with your doctor.